Company: SMNR
Filing Date: 2025-04-01
Form Type: NT 10-K
Source: 0001213900-25-026468
Chunk: 0

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-04-01
Form: NT 10-K
Chunk 0
---
<div align='center'>UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 12b-25</div>

SEC File Number 001-41351

<div align='center'>NOTIFICATION OF LATE FILING</div>

| (Check one): | ☒ Form 10-K | ☐ Form 20-F  | ☐ Form 11-K  | ☐ Form 10-Q |
|              | ☐ Form 10-D | ☐ Form N-CEN | ☐ Form N-CSR |             |

| For Period Ended: December 31, 2023                                                    |
|:---------------------------------------------------------------------------------------|
| ☐ Transition Report on Form 10-K                                                       |
| ☐ Transition Report on Form 20-F                                                       |
| ☐ Transition Report on Form 11-K                                                       |
| ☐ Transition Report on Form 10-Q                                                       |
| For the Transition Period Ended:______________________________________________________ |

<div align='center'>Read Instruction (on back page) Before Preparing Form. Please Print or Type.

Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.</div>

If the notification relates to a portion of the
filing checked above, identify the Item(s) to which the notification relates:

<div align='center'>PART I

REGISTRANT INFORMATION

DENALI CAPITAL ACQUISITION CORP.

Full Name of Registrant

N/A

Former Name if Applicable

437 Madison Avenue 27 thFloor Address of Principal Executive Office (Street and Number)

New York, NY 10022

City, State and Zip Code

PART II

RULES 12b-25(b) AND (c)</div>

If the subject report could not be filed without
unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box
if appropriate)

| ☒ | -a | The reason described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;                                                                                                                                                                                                                                                                                                                                      |
| ☒ | -b | The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-CEN or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form